
Haw Par Corporation Ltd
SGX:H02


to continue H02 research
to continue H02 research
You've reached your weekly stock limit.
Sign UpHaw Par Corporation Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9.75
13.29
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Haw Par Corporation Ltd hold over its rivals?
What risks and challenges
does Haw Par Corporation Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Haw Par Corporation Ltd.
Provide an overview of the primary business activities
of Haw Par Corporation Ltd.
What unique competitive advantages
does Haw Par Corporation Ltd hold over its rivals?
What risks and challenges
does Haw Par Corporation Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Haw Par Corporation Ltd.
Provide P/S
for Haw Par Corporation Ltd.
Provide P/E
for Haw Par Corporation Ltd.
Provide P/OCF
for Haw Par Corporation Ltd.
Provide P/FCFE
for Haw Par Corporation Ltd.
Provide P/B
for Haw Par Corporation Ltd.
Provide EV/S
for Haw Par Corporation Ltd.
Provide EV/GP
for Haw Par Corporation Ltd.
Provide EV/EBITDA
for Haw Par Corporation Ltd.
Provide EV/EBIT
for Haw Par Corporation Ltd.
Provide EV/OCF
for Haw Par Corporation Ltd.
Provide EV/FCFF
for Haw Par Corporation Ltd.
Provide EV/IC
for Haw Par Corporation Ltd.
Show me price targets
for Haw Par Corporation Ltd made by professional analysts.
What are the Revenue projections
for Haw Par Corporation Ltd?
How accurate were the past Revenue estimates
for Haw Par Corporation Ltd?
What are the Net Income projections
for Haw Par Corporation Ltd?
How accurate were the past Net Income estimates
for Haw Par Corporation Ltd?
What are the EPS projections
for Haw Par Corporation Ltd?
How accurate were the past EPS estimates
for Haw Par Corporation Ltd?
What are the EBIT projections
for Haw Par Corporation Ltd?
How accurate were the past EBIT estimates
for Haw Par Corporation Ltd?
Compare the revenue forecasts
for Haw Par Corporation Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Haw Par Corporation Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Haw Par Corporation Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Haw Par Corporation Ltd compared to its peers.
Compare the P/E ratios
of Haw Par Corporation Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Haw Par Corporation Ltd with its peers.
Analyze the financial leverage
of Haw Par Corporation Ltd compared to its main competitors.
Show all profitability ratios
for Haw Par Corporation Ltd.
Provide ROE
for Haw Par Corporation Ltd.
Provide ROA
for Haw Par Corporation Ltd.
Provide ROIC
for Haw Par Corporation Ltd.
Provide ROCE
for Haw Par Corporation Ltd.
Provide Gross Margin
for Haw Par Corporation Ltd.
Provide Operating Margin
for Haw Par Corporation Ltd.
Provide Net Margin
for Haw Par Corporation Ltd.
Provide FCF Margin
for Haw Par Corporation Ltd.
Show all solvency ratios
for Haw Par Corporation Ltd.
Provide D/E Ratio
for Haw Par Corporation Ltd.
Provide D/A Ratio
for Haw Par Corporation Ltd.
Provide Interest Coverage Ratio
for Haw Par Corporation Ltd.
Provide Altman Z-Score Ratio
for Haw Par Corporation Ltd.
Provide Quick Ratio
for Haw Par Corporation Ltd.
Provide Current Ratio
for Haw Par Corporation Ltd.
Provide Cash Ratio
for Haw Par Corporation Ltd.
What is the historical Revenue growth
over the last 5 years for Haw Par Corporation Ltd?
What is the historical Net Income growth
over the last 5 years for Haw Par Corporation Ltd?
What is the current Free Cash Flow
of Haw Par Corporation Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Haw Par Corporation Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
SG |
![]() |
Haw Par Corporation Ltd
SGX:H02
|
2.6B SGD | 26.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
753.1B USD | 36.4 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368B USD | 12.3 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 12.8 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
206.3B CHF | 9.4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
186.1B CHF | 10.6 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
159.1B GBP | 130.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
200.5B USD | 8.6 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 261.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
137.9B USD | 7.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
SG |
![]() |
Haw Par Corporation Ltd
SGX:H02
|
Average EV/EBITDA:
396.6
26.8
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
36.4
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
12.3
|
7%
|
1.8 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
12.8
|
13%
|
1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.4
|
5%
|
1.9 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10.6
|
5%
|
2.1 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
130.6
|
10%
|
13.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
8.6
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
261.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.5
|
2%
|
3.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.